The board of directors of Lansen Pharmaceutical Holdings Limited announced that Ms. Liu Xuezi and Ms. Tao Fang Fang have been appointed as members of Executive Committee with effect from 16 December 2016. Ms. Liu is an non-executive director of company. Ms. Liu joined Cathay International Holdings Limited ("CIH") in 2002 and has been working in the corporate development department and asset management department. She is currently the vice president and co-head of asset management department of CIH and the director of various members of the Group. Ms. Liu has over 14 years of experience in mergers and acquisitions and asset management. Before joining CIH, Ms. Liu was the head of the Asia-Pacific region of a US network infrastructure company, and was responsible for the start-up and expansion of the company's business in Asia. Ms. Tao joined the group of CIH in 2007. She is currently the director of various members of the Group. She was the non-executive Directors of the company from 8 January 2010 to 30 March 2016.